Plug Power Strengthens Financial Flexibility with Restructured and Increased Generate Capital Loan Facility
LATHAM, N.Y., May 07, 2020 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a leading provider of hydrogen engines and […]
Argonaut Gold and Alio Gold Merger Receives Positive Recommendation from Proxy Advisory Firm, Glass, Lewis & Co.
TORONTO and VANCOUVER, British Columbia, May 07, 2020 (GLOBE NEWSWIRE) — Argonaut Gold Inc. (“Argonaut” or “Argonaut Gold”) (TSX: AR) […]
Orchard Therapeutics Unveils New Strategic Plan and Reports First Quarter 2020 Financial Results
Portfolio Investments More Tightly Prioritized Around High Need, High Value IndicationsFirst Disease Targets Extending Platform into Less Rare Indications DisclosedUpdated […]
Chimerix Reports First Quarter 2020 Financial Results and Provides Operational Update
DURHAM, N.C., May 07, 2020 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to […]
Laureate Education Reports First Quarter 2020 Financial Results
Prior Investments in Technology Enabled Rapid Transition to Online Learning at All InstitutionsCompany Updates Its Full-Year 2020 Guidance in Response […]
CareDx Brings the Transplant Patient Community Together
SOUTH SAN FRANCISCO, Calif., May 07, 2020 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on […]
Autolus Therapeutics Reports First Quarter 2020 Financial Results and Operational Progress
– Conference Call to be held on May 7, 2020 at 8:30 am EDT/1:30 pm BST-LONDON, May 07, 2020 (GLOBE […]
Amicus Therapeutics Announces First Quarter 2020 Financial Results and Corporate Updates
Galafold 1Q2020 Revenue of $60.5 Million Reflects Continued Strong Adoption in All Key Global Regions, On Track to Achieve 2020 Revenue Guidance […]
Stericycle, Inc. Reports Results For the First Quarter 2020
BANNOCKBURN, Ill., May 07, 2020 (GLOBE NEWSWIRE) — Stericycle, Inc. (Nasdaq: SRCL) today reported results for the first quarter ended March […]
Tonix Pharmaceuticals Enters into Research Collaboration and Exclusive License Agreement with University of Alberta to Develop Novel Horsepox-Based Vaccines, TNX-1810, TNX-1820 and TNX-1830, for the Prevention of COVID-19
NEW YORK, May 07, 2020 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage […]
